Article
In-silico evaluation of the T-cell based immune response against SARS-CoV-2 omicron variants.
Scientific reports - 25 Oct 2024
Sharma Shivangi, Roy Diya, Cherian Sarah
Abstract excerpt
During of COVID-19 pandemic, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has continuously evolved, resulting in the emergence of several new variants of concerns (VOCs) with numerous mutations. These VOCs dominate in various regions due to increased transmissibility and antibody evasion, potentially reducing vaccine effectiveness. Nonetheless, it remains uncertain whether the recent SARS-CoV-2...
Topics
Join the communities discussing this publication.
